For many emerging pharmaceutical and biotech companies, the transition from discovery into IND-enabling work can feel deceptively straightforward. A promising compound moves into toxicology studies, formulation discussions begin, manufacturing timelines start to form, and suddenly, sponsors realize just how many moving parts must align perfectly to stay on schedule.
What often gets overlooked is the role that API development plays in coordinating the entire process.
According to Olon USA CEO Robert Poe, one of the biggest challenges sponsors face is not necessarily the science itself. It is the disconnect between timelines, communication, and operational expectations across multiple vendors and development groups.
The First Breakdown Usually Happens with Timing
One of the most common issues sponsors encounter is delayed API readiness. Toxicology and formulation partners frequently need material onsite weeks or even months before scheduled manufacturing or study initiation dates.
For formulation manufacturers, unused suite time can become extremely expensive. If API material is delayed, sponsors may still be responsible for paying daily facility fees while operations sit idle.
Toxicology studies can create even larger financial risks. Larger animal studies often require test subjects to be ordered six to nine months in advance, making accurate forecasting critical from the earliest planning stages.
Without coordination between API development, tox partners, and formulation groups, small timeline shifts can quickly become major financial setbacks.
Why Sponsors Need a Central CMC Anchor
Many small and virtual biotech companies simply do not have deep internal CMC expertise. They may understand clinical strategy or drug product development, but underestimate the complexity and timing involved in scaling API manufacturing.
This is where Olon USA positions itself differently.
Rather than functioning as a disconnected API supplier, Olon USA often works as a central CMC anchor that helps coordinate communication between formulation providers, toxicology groups, analytical teams, and manufacturing partners.
That coordination can include:
- Aligning API delivery schedules with tox and formulation timelines
- Helping sponsors identify trusted development partners
- Managing communication between vendors
- Assisting with project management oversight
- Forecasting scale-up and material requirements early
The result is a more connected development process with fewer surprises downstream.
The “One-Stop Shop” Myth
Many sponsors assume that large integrated organizations automatically solve these coordination challenges. In reality, that is not always the case.
As Poe explains, many large “one-stop-shop” organizations are still operating through multiple acquired business units, often with separate project managers, independent quality systems, and siloed communication structures.
By contrast, Olon USA’s approach focuses on building direct communication pathways between highly specialized partners while maintaining centralized visibility into the overall program timeline.
That flexibility becomes especially valuable when inevitable changes occur.
A manufacturing delay of a few days may not sound catastrophic, but proactive communication can prevent that delay from disrupting formulation schedules, tox studies, or downstream manufacturing campaigns.
Strong Communication Prevents Expensive Mistakes
Well-coordinated development programs rarely succeed because everything goes perfectly. They succeed because all parties understand the timeline, decision points, and contingency plans before problems arise.
For sponsors trying to accelerate toward IND submission or early clinical milestones, those communication structures can significantly reduce both operational risk and unnecessary costs.
At the center of that effort is often the API team itself.
When API development groups become involved early enough to help shape timelines, material forecasting, and formulation planning, sponsors gain a much stronger foundation for the rest of the program.
And according to Olon USA, that early involvement can fundamentally change the trajectory of development. Contact Olon USA today to learn more about how we can accelerate your project.

